Loading company…
Riskpilot
← Back to search
Sign in
Get full access
R.M.S. AS
AS
Active
Org 919814799
Skagevegen 78, 5258 Blomsterdalen
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2017
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
-56089.8%
Financial strength
Net profit 2024
NOK 0
0 employees
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK 0
—
Net profit
NOK 0
—
Total assets
NOK 147
+0%
Equity
NOK -82K
+0%
Employees
0
—
Company information
Legal name
R.M.S. AS
Org number
919814799
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30. oktober 2017
Share capital
NOK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Investere i andre selskap.
Contact
Address
Skagevegen 78, 5258 Blomsterdalen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−16
−2
−0
0
0
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−16
−2
−0
0
0
Net financials
0
−413
0
0
0
Profit before tax
−16
−414
−0
0
0
Tax
−0
−0
−0
−0
−0
Net profit
−16
−414
−0
0
0
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
415
0
0
0
0
Equity
332
−82
−82
−82
−82
Long-term debt
0
0
0
0
0
Short-term debt
83
83
83
83
83
Total debt
83
83
83
83
83
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Equity ratio
-56089.8%
This company
38.2%
Market median
-146932% vs market
2020
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
CL
Camilla Lindelid Strand
Chairman
2017
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
R.M.S. AS
(this company)
ABLEON MEDICAL AS
Board network connections
Board members of R.M.S. AS also hold positions in
0
other companies.
Person
Role here
Other companies
Camilla Lindelid Strand
Chairman
0 companies